Demography, patterns of care, and survival outcomes in patients with salivary duct carcinoma: an individual patient data analysis of 857 patients.
Her2/neu overexpression
adjuvant
androgen deprivation therapy
androgen receptor
carcinoma
parotid
patterns of care
radiotherapy
salivary duct
surgery
Journal
Future science OA
ISSN: 2056-5623
Titre abrégé: Future Sci OA
Pays: England
ID NLM: 101665030
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
received:
21
04
2021
accepted:
23
02
2022
entrez:
4
4
2022
pubmed:
5
4
2022
medline:
5
4
2022
Statut:
epublish
Résumé
Salivary duct carcinoma (SDC) is a rare and aggressive malignancy. The optimal treatment protocols are debated. A systematic search and individual patient data analysis of published cases of SDC was performed. SPSS v21 was used for statistical analysis. Data of 857 patients available. Median overall survival (OS) and progression-free survival (PFS) of the entire cohort 42 months and 24 months. Nodal involvement, males, primary size >5 cm, androgen receptor (AR) negativity significantly worse OS. Patients with surgery had a favorable median PFS (p = 0.000) and OS (p = 0.077). Patients with adjuvant radiation had better PFS (30 vs 18 months; p = 0.077). SDC has modest survival. Surgery and adjuvant radiation should be advocated for all patients. AR expression appears prognostic for survival.
Identifiants
pubmed: 35369277
doi: 10.2144/fsoa-2021-0052
pmc: PMC8965816
doi:
Types de publication
Journal Article
Langues
eng
Pagination
FSO791Informations de copyright
© 2022 Bhanu Prasad Venkatesulu.
Déclaration de conflit d'intérêts
Financial & competing interests disclosure The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript.
Références
Eur J Cancer. 2019 Mar;110:62-70
pubmed: 30771738
Cancers (Basel). 2017 Feb 08;9(2):
pubmed: 28208703
Front Oncol. 2019 Aug 02;9:701
pubmed: 31428578
J Clin Oncol. 2019 Jan 10;37(2):125-134
pubmed: 30452336
Avicenna J Med. 2012 Jul;2(3):71-73
pubmed: 23826550
Hum Pathol. 2019 Nov;93:30-36
pubmed: 31430492
Head Neck. 2018 Mar;40(3):605-613
pubmed: 29272069
Head Neck. 2016 Apr;38 Suppl 1:E820-6
pubmed: 25916947
Head Neck. 2014 May;36(5):694-701
pubmed: 23606370
JAMA Otolaryngol Head Neck Surg. 2016 Nov 1;142(11):1100-1110
pubmed: 27541166
Adv Radiat Oncol. 2017 Apr 06;2(2):159-166
pubmed: 28740927
Clin Cancer Res. 2016 Sep 15;22(18):4623-33
pubmed: 27103403
Pol J Pathol. 2008;59(4):205-10
pubmed: 19391487
J Oral Pathol Med. 2018 Aug;47(7):691-695
pubmed: 29863801
Case Rep Oncol. 2018 May 02;11(2):252-257
pubmed: 29867432
JAMA Otolaryngol Head Neck Surg. 2016 May 1;142(5):489-95
pubmed: 26939990